While exact pharmacokinetic data in humans is limited, early studies in rodents and anecdotal reports suggest that BPC-157 clears the bloodstream within 46 hours after injection
It's important to note that individual responses to TB-500 can vary, and the occurrence of side effects may depend on factors such as dosage, frequency of use, and individual sensitivity
43 Researchers from one review bluntly concluded that BPC-157 may not be the right choice, especially in situations where we are not aware of the presence of cancer cells in our body 44 In other words, you might not know you have microscopic cancer cells, and ramping up healing pathways could give them an edge
However, the researchers noted that statistically significant effects were weak and in part could be due to incidental change in the placebo group
For more on the individual components, see: What Is BPC-157